Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-48,882
Closed -$271K 3069
2025
Q2
$271K Sell
48,882
-2,947
-6% -$23.3K ﹤0.01% 2359
2025
Q1
$636K Buy
+51,829
New +$791K ﹤0.01% 1969
2022
Q4
Sell
-45,696
Closed -$240K 3114
2022
Q3
$240K Sell
45,696
-77,632
-63% -$584K ﹤0.01% 3029
2022
Q2
$1.11M Buy
123,328
+111,286
+924% +$1.29M ﹤0.01% 2381
2022
Q1
$213K Buy
+12,042
New +$375K ﹤0.01% 3081

Other funds holding GOCO

Marshall Wace's GOCO Position: Q3 2025 in Review

Marshall Wace sold out of GoHealth (GOCO) in Q3 2025, closing a stake of 48,882 shares — an estimated $271K sold.

Marshall Wace first reported a position in GOCO in Q1 2022 and held it in 5 quarters. The position peaked at $1.11M in Q2 2022. 62 funds tracked by Wall St. Rank hold GOCO as of Q3 2025.

  • Marshall Wace reported no remaining GoHealth position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 48,882 GoHealth shares in Q3 2025, an estimated $271K.
  • Marshall Wace first reported a position in GoHealth in Q1 2022 and held it in 5 quarters.
  • Marshall Wace's GoHealth position peaked at $1.11M in Q2 2022.
  • 62 funds tracked by Wall St. Rank held GoHealth as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.